Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling pain condition resulting
from chemotherapy for cancer. Severe acute CIPN may require chemotherapy dose …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

Commonly used chemotherapeutic agents in oncology/hematology practice, causing toxic
peripheral neuropathy, include taxanes, platinum compounds, vinca alkaloids, proteasome …

Neurotoxicity is a burdensome side effect of platinum-based chemotherapy that prevents
administration of the full efficacious dosage and often leads to treatment withdrawal …

Platinum‐induced peripheral neurotoxicity (PIPN) is a common side effect of platinum‐
based chemotherapy that may cause dose reduction and discontinuation, with oxaliplatin …

Background With improved survivorship rates for colorectal cancer (CRC), more CRC
survivors are living with long-term disease and treatment side effects. Little research exists …

Purpose The aim of this study was to systematically review the literature on the influence of
oxaliplatin administration (eg cumulative dose, dose intensity, number of cycles and …

Oxaliplatin is a highly neurotoxic chemotherapeutic agent routinely used for the treatment of
colorectal cancer. Recent data suggest that oxaliplatin-induced peripheral neuropathy may …

Importance Oxaliplatin-based chemotherapy is associated with debilitating peripheral
sensory neuropathy (PSN) for patients with stage III colon cancer. Objective To assess …

We set out to determine the usability of serum neurofilament light chain (sNfL), serum glial
fibrillary acidic protein (sGFAP), and retinal parameters by using optical coherence …